Related Experiment Video
Updated: Jul 7, 2026
08:18
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Design-Expert Assisted Formulation Development, Optimization, and Evaluation of Selegiline and Biochanin A Loaded
Shivani Tyagi1, Jayendra Kumar1
1Faculty of Medicine & Health Sciences, SRM Institute of Science and Technology, Delhi-NCR Campus, SRM Modinagar College of Pharmacy, Ghaziabad, Uttar Pradesh, India.
Drug Development Research
|July 6, 2026
Summary
This study developed a novel liquid-Self-nanoemulsifying drug delivery system (L-SNEDDS) for co-delivering Selegiline and Biochanin A to treat Parkinson's disease. The L-SNEDDS formulation demonstrated enhanced oral bioavailability and brain delivery, improving anti-Parkinsonian efficacy.
Area of Science:
- Pharmaceutical Sciences
- Neuroscience
- Drug Delivery Systems
Background:
- Parkinson's disease (PD) management requires effective therapeutic strategies.
- Selegiline (SEL), a monoamine oxidase type B (MAO-B) inhibitor, and Biochanin A (BCA), a neuroprotective agent, show promise for PD treatment.
- Enhancing oral delivery and brain penetration of these agents is crucial for improved efficacy.
Purpose of the Study:
- To formulate, optimize, and evaluate a liquid-Self-nanoemulsifying drug delivery system (L-SNEDDS) co-loaded with Selegiline (SEL) and Biochanin A (BCA).
- To improve the oral delivery and anti-Parkinsonian efficacy of the combined therapy for Parkinson's disease (PD).
Main Methods:
- Excipient screening and pseudo-ternary phase diagram construction to identify optimal components (propylene glycol, Tween 80, peppermint oil).
- Quality-by-Design (QbD) approach and Design-Expert software for formulation optimization.
- Characterization of L-SNEDDS physicochemical properties (droplet size, PDI, zeta potential, viscosity, self-emulsification time, conductivity).
- In vivo evaluation of oral bioavailability and brain Cmax for SEL and BCA.
Main Results:
- An optimized L-SNEDDS formulation was successfully developed with desirable physicochemical attributes, forming a stable nanoemulsion upon dilution.
- The SEL-BCA-loaded SNEDDS exhibited significantly enhanced oral bioavailability compared to a pure drug suspension.
- Higher brain Cmax values for both SEL and BCA were achieved with the SNEDDS formulation, indicating improved brain targeting.
- Elevated plasma concentrations of SEL and BCA were observed, further supporting enhanced systemic absorption.
Conclusions:
- The developed SEL-BCA L-SNEDDS is a promising combinational delivery platform for Parkinson's disease management.
- This approach has the potential to improve the therapeutic effectiveness of combined Selegiline and Biochanin A therapy.
- The L-SNEDDS strategy offers a viable route for enhancing oral delivery and brain targeting of neuroprotective agents.
Related Concept Videos
01:16Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...